Is EC-MPS effective in reducing GI toxicity of MPA? At what price?
Pape
Lars
L
Ahlenstiel
Thurid
T
D000328:Adult; D019540:Area Under Curve; D002648:Child; D041981:Gastrointestinal Tract / Q000187:drug effects*; D006084:Graft Rejection; D006801:Humans; D007107:Immune System; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D055118:Medication Adherence; D009173:Mycophenolic Acid / Q000031:analogs & derivatives* / Q000191:economics / Q000627:therapeutic use / Q000633:toxicity*; D016377:Organ Transplantation; D016032:Randomized Controlled Trials as Topic; D012306:Risk; D013608:Tablets, Enteric-Coated
D007166:Immunosuppressive Agents; D013608:Tablets, Enteric-Coated; D009173:Mycophenolic Acid